| DB ID | MyCo_3781 |
| Title | Aspergillus and Rhizopus Fungal Coinfection in a Patient With Multiple Myeloma |
| Year | 2020 |
| PMID | 32537269 |
| Fungal Diseases involved | Mucormycosis |
| Associated Medical Condition | Multiple Myeloma |
| Genus | None |
| Species | None |
| Organism | None |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | Opportunistic |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | GM |
| Biomarker Full Name | Galactomannan |
| Biomarker Type | Negative |
| Biomolecule | Protein |
| Geographical Location | USA |
| Cohort | A 77-year-old female known to have diabetes mellitus type 2, drug reaction with eosinophilia and systemic response syndrome (DRESS), and immunoglobulin G (IgG) lambda multiple myeloma presented with sudden and progressive shortness of breath for one day after her second cycle of chemotherapy, was included in the study. |
| Cohort No. | 1 |
| Age Group | 77 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | GM Assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | GM Assay |
| Up Regulation Down Regulation | Negative |
| Sequence Data | None |
| External Link | None |
